Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
11/2008
11/11/2008US7449561 nucleic acid probe hybridizable to a human mutated dystrophin and not hybridizable to wild-type human DNA
11/11/2008US7449554 Antibodies against the PRO4977 polypeptides
11/11/2008US7449551 PRO211 polypeptides
11/11/2008US7449549 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumor and cell proliferative disorders
11/11/2008US7449543 Binds to the polypeptide g34872 or binds to a calcium/calmodulin-dependent kinase II; treatment or diagnosis of central nervous system and bipolar disorders
11/11/2008US7449450 Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene products
11/11/2008US7449328 Using ribosomal nucleotide sequences as tools in the detectionand classification of microorganism; diagnosing infectious disease
11/11/2008US7449326 Detecting nucleotide sequences in sample; adhere and immbolize pure nucleotide sequences to support, elute nucleotide sequences, amplify recovered nucleotide sequences, detect amplified products
11/11/2008US7449322 Avian leukosis viruses and polypeptide display
11/11/2008US7449319 polypeptides having hydrolase enzyme activity, useful in the conversion of cellulose to sugars and/or ethanol
11/11/2008US7449318 Bacillus mHKcel cellulase
11/11/2008US7449317 Phytase enzymes, nucleic acid sequences encoding phytase enzymes and vectors and host cells incorporating same
11/11/2008US7449316 UDP-galactose: β-D-galactose-R 4-α-D-galactosyltransferase, α4Gal-T1
11/11/2008US7449310 For conferring protective immunity against F. necrophorum
11/11/2008US7449303 Use of JAG2 expression in diagnosis of plasma cell disorders
11/11/2008US7449298 separation of oligonucleotide primers extended with labels comprising fluorescent energy transfer dyes and and detection of fluorescence; fluorescence resonance energy transfer
11/11/2008US7449297 Methods of copying the methylation pattern of DNA during isothermal amplification and microarrays
11/11/2008US7449293 Oligonucleotide probe specific to spore structural gene (sspE) for use as tool in screening for anthrax
11/11/2008US7449292 Drug resistance to betal blockers; genotyping; transgenic rodents; detecting therapy
11/11/2008US7449291 Methods for identifying subjects susceptible to Charcot-Marie-Tooth neuropathy type 1C
11/11/2008US7449289 Methods for detection and identification of methicillin-resistant Staphylococcus aureus
11/11/2008US7449178 Attenuated gram negative bacteria
11/11/2008US7449176 Treatment of inflammatory bowel disease with IFN-γ inhibitors
11/11/2008US7449149 Kits useful for sequencing nucleic acids
11/06/2008WO2008134593A1 Molecular circuits
11/06/2008WO2008134077A1 Metabolic profile directed aptamer medicinal chemistry
11/06/2008WO2008132568A2 Fusion proteins binding to growth factors
11/06/2008WO2008131807A2 Splice switching oligomers for tnf superfamily receptors and their use in treatment of disease
11/06/2008WO2008112980A3 Method and system for assembly of macromolecules and nanostructures
11/06/2008WO2008112218A3 Li-rnai involved li suppression in cancer immunotherapy
11/06/2008WO2008112206A3 Compositions of variant biocatalysts for preparing enantiopure amino acids
11/06/2008WO2008112129A3 Treatment of carcinomas with a combination of egf-pathway and telomerase inhibitors
11/06/2008WO2008103367A3 Method for assembling high-purity chemical libraries, proapoptotic compounds discovered by same
11/06/2008WO2008101133A3 Methods of using genes and genetic variants to predict or diagnose inflammatory bowel disease
11/06/2008WO2008101121A3 Methods and compositions relating to promoter regulation by muc1 and klf proteins
11/06/2008WO2008094980A3 Nanoscale dna detection system using species-specific and/or disease-specific probes for rapid identification thereof
11/06/2008WO2008094599A3 Modified rna ligase for efficient 3' modification of rna
11/06/2008WO2008086006A3 Sp35 antibodies and uses thereof
11/06/2008WO2008085900A3 Methods for generating novel stabilized proteins
11/06/2008WO2008080093A3 Amylases and glucoamylases, nucleic acids encoding them and methods for making and using them
11/06/2008WO2008077022A3 Himf and btk in pulmonary, cardiac, and inflammation disorders
11/06/2008WO2008073201A9 Compositions and methods for identifying agents that alter expression of survivin
11/06/2008WO2008073177A3 Expression profiles associated with irinotecan treatment
11/06/2008WO2008066868A3 Method of separating target dna from mixed dna
11/06/2008WO2008064082A3 Methods for rna desilylation
11/06/2008WO2008063331A3 Modified gp140 envelope polypeptides of hiv-1 isolates, compositions, stabilized trimeric complexes, and uses thereof
11/06/2008WO2008061091A3 Antisense guanidinium peptide nucleic acid (gpna) oligonucleotides as antitumor agents
11/06/2008WO2008057234A3 Modulation of t cell signaling threshold and t cell sensitivity to antigens
11/06/2008WO2008054822A3 Compositions comprising alternatively spliced tissue factor (as tf) and methods for use
11/06/2008WO2008045819A3 Detection and identification of organisms via analysis of nucleic acid sequences
11/06/2008WO2008042510A3 Genes and gene products differentially expressed during heart failure
11/06/2008WO2008037036A3 Oligonucleotide arrays
11/06/2008WO2008030429A3 Novel haplotype of human t2r receptor ht2r50 and its use in assays for identifying human bitter taste modulators
11/06/2008WO2008022334A3 Diagnostic methods for detecting congenital bone defects
11/06/2008WO2008019305A3 Improved synthesis of labeled probes
11/06/2008WO2008013949A3 Molecular design of thermostable alcohol dehydrogenase for synthesis for chiral aromatic alcohols
11/06/2008WO2007143584A3 RNAi-MEDIATED INHIBITION OF STROMAL CELL-DERIVED FACTOR 1-RELATED TARGETS FOR TREATMENT OF NEOVASCULARIZATION-RELATED CONDITIONS
11/06/2008WO2007121156A3 Rnai-mediated inhibition of histamine receptor h1-related conditions
11/06/2008WO2007112263A3 Monomer compositions for the synthesis of rna, methods of synthesis, and methods of deprotection
11/06/2008WO2007112247A3 Determination of methylated dna
11/06/2008WO2007101063A3 Treatment of development-related disorders
11/06/2008WO2007094762A3 Novel plant homeodomain protein-encoding genes and their uses
11/06/2008WO2006069017A3 Transgenic plants with enhanced agronomic traits
11/06/2008WO2006046978A3 Cationic peptide-mediated transformation
11/06/2008WO2005028633A3 Modulation of rankl expression
11/06/2008US20080276336 Methods For Identifying Proteins With Starch Phosphorylating Enzymatic Activity
11/06/2008US20080276335 Nucleic acid molecules and other molecules associated with plants
11/06/2008US20080275229 Method for increasing the speed of nucleic acid amplification reactions
11/06/2008US20080275228 Using apparatus comprising adsorbent solid phase to recover nucleotide sequences from specimen fluids; DNA recovery
11/06/2008US20080275219 Multimolecular complexes for cell-free synthesis of preferential proteins
11/06/2008US20080275139 Cyclodextrin-Containing Polymers and Uses Thereof
11/06/2008US20080275039 Geldanamycin Derivatives and the Method for Biosynthesis Thereof
11/06/2008US20080274996 Therapy for cancer; Alzheimer's disease; using Rna sequences; control degradation , block translation of messenger Rna ; transcription product of target gene encoding clusterin
11/06/2008US20080274991 Nucleic Acids Against Viruses, in Particular Hiv
11/06/2008US20080274990 Cog47 Protein and S100beta Gene Polymorphism
11/06/2008US20080274989 Rna Interference Suppression of Neurodegenerative Diseases and Methods of Use Thereof
11/06/2008US20080274988 Microarray-Mediated Diagnosis of Herpes Virus Infection by Monitoring Host's Differential Gene Expression Upon Infection
11/06/2008US20080274970 Vascular adhesion molecules and modulation of their function
11/06/2008US20080274969 Albumin-Fused Kunitz Domain Peptides
11/06/2008US20080274967 Variants of Pigment Epithelium Derived Factor and Uses Thereof
11/06/2008US20080274962 Voltage Dependent Anion Channel (Vdac1) Compositions and Methods of Use Thereof for Regulating Apoptosis
11/06/2008US20080274959 Actinomadura Chromoprotein, Apoprotein and Gene Cluster
11/06/2008US20080274958 Glycosylation of peptides via o-linked glycosylation sequences
11/06/2008US20080274950 Intensify binding between cadherin molecules by reducing intramolecular binding within the cadherin molecules; reduce ionic bonding
11/06/2008US20080274542 Canine and feline 5T4 polypeptide sequences for use in generating vaccine for prevention and treatment of cell proliferative disorders; veterinary medicine
11/06/2008US20080274531 Exo-Specific Amylase Polypeptides, Nucleic Acids Encoding Those Polypeptides And Uses Thereof
11/06/2008US20080274520 Novel Gene Sms 37
11/06/2008US20080274510 Synthetic genes
11/06/2008US20080274504 Expression vector comprising nucleotide sequences coding human estrogen receptor for use as negative regulator of heregulin and treatment for prostatic and breast cancers
11/06/2008US20080274503 Modified Shine-Dalgarno Sequences and Methods of Use Thereof
11/06/2008US20080274500 Using trangenic fusarium as bioreactor for propagation of heterologous polypeptides; improving heterologous gene expression
11/06/2008US20080274472 Novel kinases and uses thereof
11/06/2008US20080274465 Method for Breast Cancer Diagnosis/Prognosis
11/06/2008US20080274462 Universal bases for nucleic acid analyses, methods for using universal bases, and kits comprising universal bases
11/06/2008US20080274455 Use Of Genes As Molecular Markers In Diagnosis Of Schizophrenia And Diagnostic Kit For The Same
11/06/2008US20080274449 Assay for detection of human parvovirus b19 nucleic acid
11/06/2008US20080274155 Chimeric Cannulae Proteins, Nucleic Acids Encoding Them And Methods For Making And Using Them
11/06/2008US20080274140 nucleic acid molecules that encode an immunogen in combination with one or more of CTACK protein, TECK protein, MEC protein and functional fragments thereof and/or an isolated nucleic acid molecule that encodes such a protein; inducing mucosal immune responses
11/06/2008US20080274137 to improve expression of exogenous polypeptides, such as antigen, epitope, immunogen, peptide or polypeptide of interest; insertion of transposon between kanamycin resistance gene promoter and translation initiation abolished kanamycin resistance and unexpectedly enabled high rates of plasmid replication
11/06/2008US20080274130 Rabies Virus Vector Systems and Compositions and Methods Thereof